Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.
Journal: 1967/January - CMAJ
ISSN: 0008-4409
PUBMED: 4288576
Abstract:
A father and son are described with a condition characterized by benign hypertension, potassium deficiency, increased aldosterone secretion rate (ASR), raised plasma volume and suppressed plasma renin activity (PRA). There were intermittent elevations of urine 17-ketosteroids and 17-hydroxycorticoids (17-OHCS) but no increase in urine THS, normal circadian rhythm of plasma 17-OHCS, and normal urine 17-OHCS response to dexamethasone and intravenous ACTH. Plasma ACTH and corticosterone secretion were not elevated. Pregnanetriol excretion was normal but urine pregnanediol was increased. At operation on the father no adrenal tumour was found; the excised left adrenal weighed 7 g. and showed nodular cortical hyperplasia; juxtaglomerular cells showed only occasional granules. Following operation hypertension persisted and ASR was half the preoperative value. All abnormalities in father and son were relieved by dexamethasone (DM) 2 mg. daily. The condition recurred following cessation of DM but was relieved by a second course of treatment. No such response to DM was seen in a normal subject or in a patient with Conn's syndrome. For a number of reasons it is suggested that patients with hypertension, increased ASR and low PRA be given a trial of dexamethasone treatment before undergoing adrenal surgery.
Relations:
Content
Citations
(55)
References
(23)
Diseases
(3)
Drugs
(3)
Chemicals
(2)
Organisms
(1)
Similar articles
Articles by the same authors
Discussion board
Can Med Assoc J 95(22): 1109-1119

Hypertension, Increased Aldosterone Secretion and Low Plasma Renin Activity Relieved by Dexamethasone

Abstract

A father and son are described with a condition characterized by benign hypertension, potassium deficiency, increased aldosterone secretion rate (ASR), raised plasma volume and suppressed plasma renin activity (PRA). There were intermittent elevations of urine 17-ketosteroids and 17-hydroxycorticoids (17-OHCS) but no increase in urine THS, normal circadian rhythm of plasma 17-OHCS, and normal urine 17-OHCS response to dexamethasone and intravenous ACTH. Plasma ACTH and corticosterone secretion were not elevated. Pregnanetriol excretion was normal but urine pregnanediol was increased. At operation on the father no adrenal tumour was found; the excised left adrenal weighed 7 g. and showed nodular cortical hyperplasia; juxtaglomerular cells showed only occasional granules. Following operation hypertension persisted and ASR was half the preoperative value. All abnormalities in father and son were relieved by dexamethasone (DM) 2 mg. daily. The condition recurred following cessation of DM but was relieved by a second course of treatment. No such response to DM was seen in a normal subject or in a patient with Conn's syndrome. For a number of reasons it is suggested that patients with hypertension, increased ASR and low PRA be given a trial of dexamethasone treatment before undergoing adrenal surgery.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • LAIDLAW JC, YENDT ER, BIRD CE, GORNALL AG. HYPERTENSION DUE TO RENAL ARTERY OCCLUSION SIMULATING PRIMARY ALDOSTERONISM. Can Med Assoc J. 1964 Jan 25;90:321–325.[PMC free article] [PubMed] [Google Scholar]
  • LARAGH JH, ULICK S, JANUSZEWICZ V, DEMING QB, KELLY WG, LIEBERMAN S. Aldosterone secretion and primary and malignant hypertension. J Clin Invest. 1960 Jul;39:1091–1106.[PMC free article] [PubMed] [Google Scholar]
  • CONN JW, KNOPF RF, NESBIT RM. CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES. Am J Surg. 1964 Jan;107:159–172. [PubMed] [Google Scholar]
  • SLATON PE, BIGLIERI EG. HYPERTENSION AND HYPERALDOSTERONISM OF RENAL AND ADRENAL ORIGIN. Am J Med. 1965 Mar;38:324–336. [PubMed] [Google Scholar]
  • CONN JW, ROVNER DR, COHEN EL. NORMAL AND ALTERED FUNCTION OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN MAN: APPLICATIONS IN CLINICAL AND RESEARCH MEDICINE. Ann Intern Med. 1965 Aug;63:266–284. [PubMed] [Google Scholar]
  • AUST JB, CHOU SN, MARVIN JF, BRACKNEY EL, MOORE GE. A rapid method for clinical total blood volume determination using radioactive iodinated human serum albumin (RIHSA). Proc Soc Exp Biol Med. 1951 Jul;77(3):514–518. [PubMed] [Google Scholar]
  • HAUGEN HN, BLEGEN EM. The true endogenous creatinine clearance. Scand J Clin Lab Invest. 1953;5(1):67–71. [PubMed] [Google Scholar]
  • DOOLAN PD, ALPEN EL, THEIL GB. A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med. 1962 Jan;32:65–79. [PubMed] [Google Scholar]
  • REDDY WJ. Modification of the Reddy-Jenkins-Thorn method for the estimation of 17-hydroxycorticoids in urine. Metabolism. 1954 Nov;3(6):489–492. [PubMed] [Google Scholar]
  • Callow NH, Callow RK, Emmens CW. Colorimetric determination of substances containing the grouping -CH(2).CO- in urine extracts as an indication of androgen content. Biochem J. 1938 Aug;32(8):1312–1331.[PMC free article] [PubMed] [Google Scholar]
  • HENKE WJ, DOE RP, JACOBSON ME. A test of pituitary reserve utilizing intravenous SU-4885, with a new method for extraction of 11-desoxvcorticosteroids. J Clin Endocrinol Metab. 1960 Nov;20:1527–1531. [PubMed] [Google Scholar]
  • ULICK S, VETTER KK. SIMULTANEOUS MEASUREMENT OF SECRETORY RATES OF ALDOSTERONE AND 18-HYDROXYCORTICOSTERONE. J Clin Endocrinol Metab. 1965 Aug;25:1015–1026. [PubMed] [Google Scholar]
  • ITTRICH G. [A method for the clinical routine determination of urinary estrogens]. Zentralbl Gynakol. 1960 Mar 12;82:429–438. [PubMed] [Google Scholar]
  • NEY RL, SHIMIZU N, NICHOLSON WE, ISLAND DP, LIDDLE GW. CORRELATION OF PLASMA ACTH CONCENTRATION WITH ADRENOCORTICAL RESPONSE IN NORMAL HUMAN SUBJECTS, SURGICAL PATIENTS, AND PATIENTS WITH CUSHING'S DISEASE. J Clin Invest. 1963 Nov;42:1669–1677.[PMC free article] [PubMed] [Google Scholar]
  • LAIDLAW JC, REDDY WJ, JENKINS D, HAYDAR NA, RENOLD AE, THORN GW. Advances in the diagnosis of altered states of adrenocortical function. N Engl J Med. 1955 Nov 3;253(18):747–753. [PubMed] [Google Scholar]
  • LAIDLAW JC, REDDY WJ, JENKINS D, HAYDAR NA, RENOLD AE, THORN GW. Advances in the diagnosis of altered states of adrenocortical function. N Engl J Med. 1955 Nov 3;253(18):747–753. [PubMed] [Google Scholar]
  • KAPLAN NM, SILAH JG. THE EFFECT OF ANGIOTENSIN II ON THE BLOOD PRESSURE IN HUMANS WITH HYPERTENSIVE DISEASE. J Clin Invest. 1964 Apr;43:659–669.[PMC free article] [PubMed] [Google Scholar]
  • FISHER BF, FISHER ER. Observations on the eosinophil count in man; a proposed test of adrenal cortical function. Am J Med Sci. 1951 Feb;221(2):121–132. [PubMed] [Google Scholar]
  • BARTTER FC, DUNCAN LE, Jr, LIDDLE GW. Dual mechanism regulating adrenocortical function in man. Am J Med. 1956 Sep;21(3):380–386. [PubMed] [Google Scholar]
  • BONGIOVANNI AM, EBERLEIN WR. Plasma and urinary corticosteroids in the hypertensive form of congenital adrenal hyperplasia. J Biol Chem. 1956 Nov;223(1):85–94. [PubMed] [Google Scholar]
  • KOWARSKI A, FINKELSTEIN JW, SPAULDING JS, HOLMAN GH, MIGEON CJ. ALDOSTERONE SECRETION RATE IN CONGENITAL ADRENAL HYPERPLASIA. A DISCUSSION OF THE THEORIES ON THE PATHOGENESIS OF THE SALT-LOSING FORM OF THE SYNDROME. J Clin Invest. 1965 Sep;44:1505–1513.[PMC free article] [PubMed] [Google Scholar]
  • CONN JW, CONN ES. Primary aldosteronism versus hypertensive disease with secondary aldosteronism. Recent Prog Horm Res. 1961;17:389–414. [PubMed] [Google Scholar]
  • THERIEN B, MELLINGER RC, CALDWELL JR, HOWARD PJ. Primary aldosteronism due to adrenal hyperplasia; occurrence in a boy aged 10 years. AMA J Dis Child. 1959 Jul;98(1):90–99. [PubMed] [Google Scholar]
  • SZENAS P, PATTEE CJ. Studies on adrenocortical function in obesity. J Clin Endocrinol Metab. 1959 Mar;19(3):344–350. [PubMed] [Google Scholar]
Abstract
A father and son are described with a condition characterized by benign hypertension, potassium deficiency, increased aldosterone secretion rate (ASR), raised plasma volume and suppressed plasma renin activity (PRA). There were intermittent elevations of urine 17-ketosteroids and 17-hydroxycorticoids (17-OHCS) but no increase in urine THS, normal circadian rhythm of plasma 17-OHCS, and normal urine 17-OHCS response to dexamethasone and intravenous ACTH. Plasma ACTH and corticosterone secretion were not elevated. Pregnanetriol excretion was normal but urine pregnanediol was increased. At operation on the father no adrenal tumour was found; the excised left adrenal weighed 7 g. and showed nodular cortical hyperplasia; juxtaglomerular cells showed only occasional granules. Following operation hypertension persisted and ASR was half the preoperative value. All abnormalities in father and son were relieved by dexamethasone (DM) 2 mg. daily. The condition recurred following cessation of DM but was relieved by a second course of treatment. No such response to DM was seen in a normal subject or in a patient with Conn's syndrome. For a number of reasons it is suggested that patients with hypertension, increased ASR and low PRA be given a trial of dexamethasone treatment before undergoing adrenal surgery.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.